ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Tilray Brands Inc

Tilray Brands Inc (TLRY)

1.63
-0.02
(-1.21%)
Closed 10 October 7:00AM
1.63
0.00
(0.00%)
After Hours: 10:59AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.63
Bid
1.63
Offer
1.65
Volume
36,459,474
1.62 Day's Range 1.67
1.50 52 Week Range 2.97
Market Cap
Previous Close
1.65
Open
1.66
Last Trade Time
Financial Volume
US$ 59,538,080
VWAP
1.633
Average Volume (3m)
22,614,709
Shares Outstanding
842,961,757
Dividend Yield
-
PE Ratio
-5.57
Earnings Per Share (EPS)
-0.29
Revenue
804.73M
Net Profit
-244.98M

About Tilray Brands Inc

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists ... Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. Show more

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Tilray Brands Inc is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker TLRY. The last closing price for Tilray Brands was US$1.65. Over the last year, Tilray Brands shares have traded in a share price range of US$ 1.50 to US$ 2.97.

Tilray Brands currently has 842,961,757 shares in issue. The market capitalisation of Tilray Brands is US$1.39 billion. Tilray Brands has a price to earnings ratio (PE ratio) of -5.57.

Tilray Brands (TLRY) Options Flow Summary

Overall Flow

Bullish

Net Premium

34k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

TLRY Latest News

Tilray Brands Launches Charlotte’s Web™ CBD Gummies in Canada

TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, announced the launch of new...

Blue Point Brewing Hosts 20th Annual Cask Ales Festival

PATCHOGUE, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island’s original craft brewery and a subsidiary of Tilray Brands, (NASDAQ: TLRY and TSX: TLRY), proudly...

Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2025 Financial Results on October 10, 2024

NEW YORK and LEAMINGTON, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged...

Shock Top’s Bold New Hard Iced LiiT Tea is Here

PORTLAND, Ore., Sept. 26, 2024 (GLOBE NEWSWIRE) -- The Shock Top Company, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is excited to introduce its latest innovation: Shock...

Tilray Brands Leverages Hemp and Beverage Scale to Launch Hemp-Derived Delta-9 THC Drinks in Key Markets Across the United States

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY and TSX: TLRY), through its newly formed Tilray Alternative Beverages business unit...

Shock Top Announces its Official Craft Beer Sponsorship of University of Missouri Athletics

PORTLAND, Ore., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Today, The Shock Top Company, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), proudly announces a new partnership with Mizzou...

Tilray Medical Launches Redecan Cannabis Brand in Australia

NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.055-3.264094955491.6851.771.625265409321.6754118CS
4-0.07-4.117647058821.71.881.625237888581.71823893CS
12-0.25-13.29787234041.882.151.5226147091.7938808CS
26-0.5-23.47417840382.132.5151.5233204141.87583474CS
52-0.39-19.30693069312.022.971.5227940591.96966389CS
156-8.74-84.281581485110.3713.951.5234395393.8375885CS
260-22.37-93.20833333332466.981.5205324638.05978897CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MNTSMomentus Inc
US$ 1.05
(153.01%)
487.35M
BNZIBanzai International Inc
US$ 4.95
(79.35%)
37.1M
LEELee Enterprises Inc
US$ 14.165
(47.09%)
588.89k
WWWW International Inc
US$ 1.60
(37.93%)
164.47M
KXINKaixin Holdings
US$ 0.2458
(36.56%)
160.33M
BYUBAIYU Holdings Inc
US$ 0.50
(-50.50%)
6.13M
SPGCSacks Parente Golf Inc
US$ 1.83
(-48.45%)
694.11k
SKKSKK Holdings Limited
US$ 3.92
(-35.21%)
3.4M
ALCEAlternus Clean Energy Inc
US$ 0.1037
(-28.04%)
12.63M
NISNNiSun International Enterprise Development Group Company Ltd
US$ 14.23
(-25.81%)
1.09M
MNTSMomentus Inc
US$ 1.05
(153.01%)
487.23M
NVDANVIDIA Corporation
US$ 132.65
(-0.18%)
246.89M
WWWW International Inc
US$ 1.60
(37.93%)
164.46M
KXINKaixin Holdings
US$ 0.2458
(36.56%)
160.28M
SQQQProShares UltraPro Short QQQ
US$ 7.17
(-2.32%)
134.38M

TLRY Discussion

View Posts
doomed doomed 12 hours ago
Our canna naive duder no longer brags about buying Tilray on mercredi?
What happened there?
👍️0
doomed doomed 12 hours ago
She is dropping
👍️0
doomed doomed 12 hours ago
Germans in the know by-pass the shit show and order direct from BCBud with next day Canada Post 🚚.
👍️0
doomed doomed 12 hours ago

14 licenses for cannabis social clubs granted in 4 German federal states
Doomed
October 9, 2024

The number of applications and licenses granted for cannabis cultivation social clubs in Germany continued to grow throughout September, but growth has slowed month-over-month.

According to the latest data, 14 licenses have now been granted in four of Germany’s federal states, as more territories and awarding bodies solidify their application and licensing process.

The total number of confirmed cannabis social club applications has growth by 34%, from 226 in August to 303 through the last full week of September. Grown by folks for folks. German officials visited Tilray and Canopy Growth and decided to have folks grow cannabis in cannabis clubs.

That number is down from the 237% increase seen between July and August, where the number of applications grew from 67 to 226.

Despite the ongoing growth, applicants across Germany continue to struggle with uncertain or inconsistent regulations from state to state, while others report struggling to secure property in order to begin their application process.
👍️0
doomed doomed 14 hours ago
You like red? You are at the right place…
Watch nsrr5 scarf them up today…
Dude is killing it! NOT!!!
A multi-millionnaire in the making under your watch full eyes.
Ce garçon est une merveille de la nature, et riche a souhait…
Il fait chaud en Floride…
👍️0
doomed doomed 14 hours ago
You will be back to nothing just like in Canada.

You guys are cannabis naive.

Folks in the know will tell you that government weed is bunk and grey market is the only player with ANY traction in the US.

Grey market is king on prices AND quality.

Prove me wrong.
👍️0
nssrr5 nssrr5 14 hours ago
A great day to add - GL Longs
👍️0
nssrr5 nssrr5 2 days ago
We just need decriminalization and we are golden. We are stuck in the mud until that happens I believe.

Good Luck Longs
👍️0
doomed doomed 2 days ago
👍️0
Bazwar6 Bazwar6 2 days ago
https://invezz.com/news/2024/10/07/tilray-brands-stock-forecast-levels-to-watch-ahead-of-earnings/
👍️0
Bazwar6 Bazwar6 3 days ago
https://www.stocktitan.net/news/TLRY/tilray-brands-launches-charlotte-s-web-tm-cbd-gummies-in-2lk6u4v2akuf.html
👍️0
doomed doomed 3 days ago
He loads every mercredi🤣
👍️0
doomed doomed 3 days ago
Not to worry… nnsrr5 to the rescue😂
👍️0
Monksdream Monksdream 3 days ago
TLRY 10 Q due 10 October
👍️0
Moon Traveler Moon Traveler 4 days ago
Tilray's last earnings sucked. destroyed my calls. And the price was over $2.
👍️0
doomed doomed 5 days ago

Is Marijuana A Diabetic’s Answer To Alcohol
mm
By:
Amy Hansen
October 4, 2024
CannabisFeaturedMedical MarijuanaNewsRXWellness

Is Marijuana A Diabetic's Answer To Alcohol
Alcohol and mixers are always a bit a wild card if you are a diabetic, maybe cannabis can help.

Being a diabetic can be tough and you always must be aware of your blood sugar. Today, there are programs which monitor the levels and gives alerts if things are too bad. Cocktails and some other alcohol and can be full of sugar, which can play havoc with a body. Additionally, alcohol consumption can worsen diabetes-related medical complications, such as disturbances in fat metabolism, nerve damage, and eye disease. But cannabis, well, that is a different story – and it seems the knowledge it catching on. So is marijuana a diabetes answer to alcohol?

RELATED: Science Says Medical Marijuana Improves Quality Of Life


Marijuana use is becoming more common for diabetics. A recent study estimated that 9% adults with diabetes used cannabis in the last month, a 33.7% increase with nearly half (48.9%) of users were younger than 50 years. Cannabis use is also increasing among Boomer (65 and older), many of whom have diabetes and other chronic conditions.


Photo by Lepro/Getty Images
Alcohol consumption is taking a hit as more people consume marijuana. Gen Z is drifting from alcohol and consuming more. California sober has become a trend. The AARP has said cannabis has medical benefits, but what about using it as a full or partial replacement of alcohol? Cannabis is


For diabetic, drinking alcohol can cause low or high blood sugar, affect diabetes medicines, and cause other possible problems. The liver releases glucose into your blood stream as needed to help keep blood sugar at normal levels. The liver releases glucose into the blood stream help keep blood sugar at normal levels. When drinking alcohol, the liver needs to break down the alcohol. While the liver is processing alcohol, it stops releasing glucose. As a result, blood sugar levels can drop quickly, making a risks for low blood sugar (hypoglycemia).

RELATED: Biden Administration Puts A Knife Into The Cannabis Industry


While over indulging is never good, moderate vaping can avoid the sugar and carb intake received from alcohol and especially cocktails. Microdosing has also become popular.

Two important notes, there needs to be more research on dosage and use. Also, cannabis could use could increase the risk for diabetic ketoacidosis for people with type 1 diabetes. Research showed it was primarily due to worse management of diabetes, including increased intake of high-carb foods and forgetting to take medications.
👍️0
doomed doomed 6 days ago
This government weed is a comb-over.
Tilray cannot fool me.
Incompetent bunk weed growers.
How can sick Canadians afford these prices?
The gouging has to stop 🛑 now!
👍️0
doomed doomed 6 days ago
👍️0
doomed doomed 6 days ago
Dude is a serious investers.
👍️0
doomed doomed 6 days ago
Dude also bought a watch… he’s on a roll…🎯 Good call.
👍️0
nssrr5 nssrr5 6 days ago
Nice seeing a green day of trading for a change - a close at the HOD would be even better!
👍️0
doomed doomed 1 week ago
Talk is cheap and BCBUD is killer!
👍️0
doomed doomed 1 week ago
He bought 50,000 Tilray shares, 1000 Signed Bibles, 1000 Golden Shoes and counting.
Perfect score. Multi - millionnaire in the making. Dude is perfect. Great buyer.
Mexico will pay for it…🤣
👍️0
nssrr5 nssrr5 1 week ago
I hope she wins! It is what this sector has been waiting for and Tilray will ROCKET. Thanks for sharing Bazwar6!
👍️ 1
Bazwar6 Bazwar6 1 week ago
Kamala harris speaks briefly about weed

https://www.marijuanamoment.net/kamala-harris-says-we-need-to-legalize-marijuana-for-first-time-as-democratic-presidential-nominee/
👍️0
doomed doomed 1 week ago
Bunk weed.
👍️0
doomed doomed 1 week ago
Nothing came out of that visit… Culprit = tilray’s bunk weed.
👍️0
doomed doomed 1 week ago
Bunk is a bitch
👍️0
doomed doomed 1 week ago
👍️0
doomed doomed 1 week ago
Keep buying Tilray if you want to become poor
👍️0
doomed doomed 1 week ago
They cannot give it away!!!!
👍️0
13strats 13strats 1 week ago
Well. I just hit the ignore for doomed. Just to much over the top bull s!!!
👍️ 1
doomed doomed 1 week ago
You are such a bull shiter 46er.
You read all my post you freak.
What is there to read, as you guys just don’t know what is going down. You guys are MAGA style.
Investershub brass have me covered.
This place would be dead without me in it.
👍️0
doomed doomed 1 week ago
These canna naive investers have no way of knowing that Tilray’s best is bunk weed.
Germans came to Pay Tilray a visit. What they saw floored them. Nobody knew what they were doing.
Newbies at work! Growing mold at scale!!
Germany opted on cannabis clubs just like BCBUD and Spain. No large mold producers allowed in Germany. Shit is grow by people for the people. Premium small batches. Nobody gets screwed Tilray’s style.[/color]
👍️0
doomed doomed 1 week ago
Recalls hurts government bunk weed bottom line?
No problems!
They simply stop testing it…
The word has been out for years. Everybody knows it’s bunk.
Nsrr5 won’t touch it it’s so gross.🤮


Major marijuana markets still lacking controls for suspicious lab results
Chris Roberts, Reporter Forbes
October 1, 2024

The California Department of Cannabis Control revoked a commercial testing laboratory’s permit a month ago after tests at state-run labs discovered a harmful pesticide in marijuana the private lab had cleared for sale.

Many industry operators and a national association of state regulators consider oversight at so-called “reference laboratories” to be a best practice that should be standard in all state-regulated marijuana markets.

Absent reference laboratories, some states contract private, third-party labs to verify licensed cannabis labs’ compliance with safety standards as well as the reliability of THC-potency results.

But more than half of the country’s biggest marijuana markets do not have a reference lab, according to analysis by MJBizDaily, a glaring gap that critics say raises major questions about product labeling and safety.

Marijuana labs ‘cannot govern themselves’
“The cannabis testing lab markets have proven over and over again that they cannot govern themselves effectively – regulators have to provide a strong structure of governance and enforcement,” said Sarah Ahrens, president of Trichome Analytical, a New Jersey-licensed laboratory.

With regulated marijuana sales that could exceed $1 billion in 2024, New Jersey is one of the states lacking a reference laboratory to verify the safety and potency results of regulated marijuana products, according to the Cannabis Regulators Association (CANNRA), an organization representing state marijuana overseers.

Such oversight is a basic requirement to build confidence in the regulated market and steer consumers away from illicit cannabis, Ahrens said.

“I 100% believe in having an unbiased, accredited laboratory that is not licensed in the cannabis market to provide oversight services to state cannabis regulators,” she added.

“Without that – like what is happening in California right now with the pesticide contamination and THC-inflation scandals, lawsuits (and a) drop in legal sales – a market can crumble.”

States lacking reference labs
Clean and safe cannabis was one of the promises used to sell marijuana legalization to a skeptical canna experienced public…

However, allegations of “lab shopping,” in which retailers or product manufacturers seek a testing lab that will produce favorable results, have dogged the industry for years.

More recently, regulators have discovered faulty lab practices and taken action only after problems were revealed by reference labs.

As MJBizDaily reported, California’s Department of Cannabis Control has revoked the licenses of four commercial marijuana testing laboratories since December 2023 after running tests at two state reference laboratories.

Those labs, run by California’s departments of Toxic Substances Control and Food and Agriculture, discovered the commercial labs had inflated THC potency on batches sampled by as much as 50% and failed to discover banned pesticides.

The lapses by state-licensed labs led to subsequent product recalls and has shaken consumer confidence in product testing and labeling.

States with reference labs
According to CANNRA, the states that have regulated marijuana markets and are currently using a reference laboratory are:

California
Colorado
Florida
Iowa
Maryland
Montana
New Mexico
New York
Oregon
Utah
Washington
West Virginia
In Colorado, regulators set up a reference laboratory in 2017 “as part of deliberate efforts to mitigate risks of inconsistency and inaccuracy of test results in private labs,” Heather Krug, the regulatory programs branch chief at the State Public Health Laboratory, told MJBizDaily via email.

“This approach has led to improvements of the entire testing program, including the accuracy and defensibility of test results,” she added.

According to Gillian Schauer, CANNRA’s executive director, the following states are in the process of instituting reference labs:

Delaware
Illinois
Michigan
Minnesota
Mississippi
Missouri
Oklahoma
Vermont
“We’ve seen an increase in states setting up and opening reference labs – in part because they can provide important checks and balances on the third-party lab-testing system and because they allow states to test products directly to gain a better understanding of potential issues and to support inspection and investigation,” Schauer told MJBizDaily via email.

States with large populations, regulated marijuana markets and no plans to open a reference lab include:

Arizona
Pennsylvania
Massachusetts
New Jersey
Ohio
‘Secret shopper’ oversights
According to some critics, having a reference lab or a state contract with a third-party lab does not guarantee lab oversight.

In Massachusetts, the state Cannabis Control Commission had contracted with AtoZ Laboratories, a private lab, to test products selected off of store shelves through a “secret shopper” program.

But, according to a Friday report by The Boston Globe, the lab says state regulators have yet to send in any products for testing.

Earlier this year, the Massachusetts Cannabis Control Commission (CCC) fined multistate operator Holistic Industries after the company allegedly “knowingly” sold cannabis contaminated during a mold outbreak.

Notably, the situation came to light only after a whistleblower alerted authorities.

According to the CCC, the company sought out a lab that would perform tests that would overlook the mold.

Without reliable labs doing independent verification, critics say, the potency and safety profiles printed on legal cannabis products simply cannot be trusted.

“We definitely have no such lab here,” said Jeff Rawson, a Massachusetts-based scientist and frequent critic of regulators’ lack of testing oversight.

“The CCC is one of the worst for ignoring real problems in testing, avoiding our demands for more shelf tests and not recalling failed products.”

In some states, reference labs don’t appear to be pulling products from the shelves of marijuana stores to test product labels’ veracity, which raises questions as to what they are doing.

In New York, the Office of Cannabis Management (OCM) has a memorandum of understanding with a state Department of Public Health lab at the Wadsworth Center in Albany.

However, “To-date, the testing conducted by Wadsworth has not been targeted at validating the reliability of permitted laboratory results,” OCM spokesperson Taylor Randi Lee told MJBizDaily via email.

“OCM has a regulatory framework in place to promote the integrity of the laboratory testing that is conducted such as demonstration of laboratory capability for receiving testing approval, proficiency testing, ISO accreditation requirements, and on-site inspections,” she added.

Lee did not respond to further questions.

Reference lab costs
In New Jersey, medical marijuana was tested by the state-run Public Health and Environmental Laboratory (PHEL), which ceased testing cannabis after the state began licensing private labs.

Ahrens said she is among the lab operators who “pressed the New Jersey Cannabis Regulatory Commission many, many times to use PHEL as a reference lab to better govern the testing market.

“But the CRC has not made moves to enable (PHEL), and the excuse we’ve been given is that the CRC does not have the funds available to pay PHEL for such services.”

While nssr5 waits…
Home / Legal
Major marijuana markets still lacking controls for suspicious lab results
author profile pictureBy Chris Roberts, Reporter
September 30, 2024
SHARE
Just Released! Get realistic market forecasts, state-by-state insights and benchmarks with the new 2024 MJBiz Factbook member program, now with quarterly updates. Make informed decisions.

Image of a petri dish swab at a cannabis lab
(Photo by Matthew Staver for MJBizDaily/Emerald)

The California Department of Cannabis Control revoked a commercial testing laboratory’s permit a month ago after tests at state-run labs discovered a harmful pesticide in marijuana the private lab had cleared for sale.

Many industry operators and a national association of state regulators consider oversight at so-called “reference laboratories” to be a best practice that should be standard in all state-regulated marijuana markets.

ADVERTISEMENT

Absent reference laboratories, some states contract private, third-party labs to verify licensed cannabis labs’ compliance with safety standards as well as the reliability of THC-potency results.

But more than half of the country’s biggest marijuana markets do not have a reference lab, according to analysis by MJBizDaily, a glaring gap that critics say raises major questions about product labeling and safety.

Marijuana labs ‘cannot govern themselves’
“The cannabis testing lab markets have proven over and over again that they cannot govern themselves effectively – regulators have to provide a strong structure of governance and enforcement,” said Sarah Ahrens, president of Trichome Analytical, a New Jersey-licensed laboratory.

With regulated marijuana sales that could exceed $1 billion in 2024, New Jersey is one of the states lacking a reference laboratory to verify the safety and potency results of regulated marijuana products, according to the Cannabis Regulators Association (CANNRA), an organization representing state marijuana overseers.

Such oversight is a basic requirement to build confidence in the regulated market and steer consumers away from illicit cannabis, Ahrens said.

“I 100% believe in having an unbiased, accredited laboratory that is not licensed in the cannabis market to provide oversight services to state cannabis regulators,” she added.

“Without that – like what is happening in California right now with the pesticide contamination and THC-inflation scandals, lawsuits (and a) drop in legal sales – a market can crumble.”

ADVERTISEMENT

States lacking reference labs
Clean and safe cannabis was one of the promises used to sell marijuana legalization to a skeptical public.

However, allegations of “lab shopping,” in which retailers or product manufacturers seek a testing lab that will produce favorable results, have dogged the industry for years.

More recently, regulators have discovered faulty lab practices and taken action only after problems were revealed by reference labs.

As MJBizDaily reported, California’s Department of Cannabis Control has revoked the licenses of four commercial marijuana testing laboratories since December 2023 after running tests at two state reference laboratories.

Those labs, run by California’s departments of Toxic Substances Control and Food and Agriculture, discovered the commercial labs had inflated THC potency on batches sampled by as much as 50% and failed to discover banned pesticides.

The lapses by state-licensed labs led to subsequent product recalls and has shaken consumer confidence in product testing and labeling.

States with reference labs
According to CANNRA, the states that have regulated marijuana markets and are currently using a reference laboratory are:

California
Colorado
Florida
Iowa
Maryland
Montana
New Mexico
New York
Oregon
Utah
Washington
West Virginia
In Colorado, regulators set up a reference laboratory in 2017 “as part of deliberate efforts to mitigate risks of inconsistency and inaccuracy of test results in private labs,” Heather Krug, the regulatory programs branch chief at the State Public Health Laboratory, told MJBizDaily via email.

“This approach has led to improvements of the entire testing program, including the accuracy and defensibility of test results,” she added.

According to Gillian Schauer, CANNRA’s executive director, the following states are in the process of instituting reference labs:

Delaware
Illinois
Michigan
Minnesota
Mississippi
Missouri
Oklahoma
Vermont
“We’ve seen an increase in states setting up and opening reference labs – in part because they can provide important checks and balances on the third-party lab-testing system and because they allow states to test products directly to gain a better understanding of potential issues and to support inspection and investigation,” Schauer told MJBizDaily via email.

States with large populations, regulated marijuana markets and no plans to open a reference lab include:

Arizona
Pennsylvania
Massachusetts
New Jersey
Ohio
‘Secret shopper’ oversights
According to some critics, having a reference lab or a state contract with a third-party lab does not guarantee lab oversight.

In Massachusetts, the state Cannabis Control Commission had contracted with AtoZ Laboratories, a private lab, to test products selected off of store shelves through a “secret shopper” program.

But, according to a Friday report by The Boston Globe, the lab says state regulators have yet to send in any products for testing.

Earlier this year, the Massachusetts Cannabis Control Commission (CCC) fined multistate operator Holistic Industries after the company allegedly “knowingly” sold cannabis contaminated during a mold outbreak.

Notably, the situation came to light only after a whistleblower alerted authorities.

According to the CCC, the company sought out a lab that would perform tests that would overlook the mold.

Without reliable labs doing independent verification, critics say, the potency and safety profiles printed on legal cannabis products simply cannot be trusted.

“We definitely have no such lab here,” said Jeff Rawson, a Massachusetts-based scientist and frequent critic of regulators’ lack of testing oversight.

“The CCC is one of the worst for ignoring real problems in testing, avoiding our demands for more shelf tests and not recalling failed products.”

In some states, reference labs don’t appear to be pulling products from the shelves of marijuana stores to test product labels’ veracity, which raises questions as to what they are doing.

In New York, the Office of Cannabis Management (OCM) has a memorandum of understanding with a state Department of Public Health lab at the Wadsworth Center in Albany.

However, “To-date, the testing conducted by Wadsworth has not been targeted at validating the reliability of permitted laboratory results,” OCM spokesperson Taylor Randi Lee told MJBizDaily via email.

“OCM has a regulatory framework in place to promote the integrity of the laboratory testing that is conducted such as demonstration of laboratory capability for receiving testing approval, proficiency testing, ISO accreditation requirements, and on-site inspections,” she added.

Lee did not respond to further questions.

Reference lab costs
In New Jersey, medical marijuana was tested by the state-run Public Health and Environmental Laboratory (PHEL), which ceased testing cannabis after the state began licensing private labs.

Ahrens said she is among the lab operators who “pressed the New Jersey Cannabis Regulatory Commission many, many times to use PHEL as a reference lab to better govern the testing market.

“But the CRC has not made moves to enable (PHEL), and the excuse we’ve been given is that the CRC does not have the funds available to pay PHEL for such services.”
👍️0
46er 46er 1 week ago
Agree. Got rid of that crap, a while back.
👍️0
nssrr5 nssrr5 1 week ago
Oh I know but the board is so slow I enjoy the banter.

When Harris gets in this will rock.
👍️ 1
KILLAZILLA KILLAZILLA 1 week ago
ACTUALLY.....you ARE "doomed"

TLRY will be just fine...
👍️ 1
doomed doomed 1 week ago
You guys are doomed. tilray is bunk. No traction.
👍️0
doomed doomed 1 week ago
Tilray & Thailand
👍️0
13strats 13strats 1 week ago
Just hit the ignore button on his posts. Hell im tired of reading them also
👍️0
doomed doomed 1 week ago
´´I will win this game - it is only a matter of time…´´
So…nssrs5 will win this game by investing in a company that has NO TRACTION, that grows bunk weed, is way overpriced and is UNTESTED

Home / Legal
Major marijuana markets still lacking controls for suspicious lab results
Chris Roberts, Reporter
September 30, 2024

The California Department of Cannabis Control revoked a commercial testing laboratory’s permit a month ago after tests at state-run labs discovered a harmful pesticide in marijuana the private lab had cleared for sale.

Many industry operators and a national association of state regulators consider oversight at so-called “reference laboratories” to be a best practice that should be standard in all state-regulated marijuana markets.

Absent reference laboratories, some states contract private, third-party labs to verify licensed cannabis labs’ compliance with safety standards as well as the reliability of THC-potency results.

But more than half of the country’s biggest marijuana markets do not have a reference lab, according to analysis by MJBizDaily, a glaring gap that critics say raises major questions about product labeling and safety.

Marijuana labs ‘cannot govern themselves’
“The cannabis testing lab markets have proven over and over again that they cannot govern themselves effectively – regulators have to provide a strong structure of governance and enforcement,” said Sarah Ahrens, president of Trichome Analytical, a New Jersey-licensed laboratory.

With regulated marijuana sales that could exceed $1 billion in 2024, New Jersey is one of the states lacking a reference laboratory to verify the safety and potency results of regulated marijuana products, according to the Cannabis Regulators Association (CANNRA), an organization representing state marijuana overseers.

Such oversight is a basic requirement to build confidence in the regulated market and steer consumers away from illicit cannabis, Ahrens said.

“I 100% believe in having an unbiased, accredited laboratory that is not licensed in the cannabis market to provide oversight services to state cannabis regulators,” she added.

“Without that – like what is happening in California right now with the pesticide contamination and THC-inflation scandals, lawsuits (and a) drop in legal sales – a market can crumble.”

Bunk weed bonanza

States lacking reference labs
Clean and safe cannabis was one of the promises used to sell marijuana legalization to a skeptical public.

However, allegations of “lab shopping,” in which retailers or product manufacturers seek a testing lab that will produce favorable results, have dogged the industry for years.

More recently, regulators have discovered faulty lab practices and taken action only after problems were revealed by reference labs.

As MJBizDaily reported, California’s Department of Cannabis Control has revoked the licenses of four commercial marijuana testing laboratories since December 2023 after running tests at two state reference laboratories.

Those labs, run by California’s departments of Toxic Substances Control and Food and Agriculture, discovered the commercial labs had inflated THC potency on batches sampled by as much as 50% and failed to discover banned pesticides.

The lapses by state-licensed labs led to subsequent product recalls and has shaken consumer confidence in product testing and labeling.

States with reference labs
According to CANNRA, the states that have regulated marijuana markets and are currently using a reference laboratory are:

California
Colorado
Florida
Iowa
Maryland
Montana
New Mexico
New York
Oregon
Utah
Washington
West Virginia
In Colorado, regulators set up a reference laboratory in 2017 “as part of deliberate efforts to mitigate risks of inconsistency and inaccuracy of test results in private labs,” Heather Krug, the regulatory programs branch chief at the State Public Health Laboratory, told MJBizDaily via email.

“This approach has led to improvements of the entire testing program, including the accuracy and defensibility of test results,” she added.

According to Gillian Schauer, CANNRA’s executive director, the following states are in the process of instituting reference labs:

Delaware
Illinois
Michigan
Minnesota
Mississippi
Missouri
Oklahoma
Vermont
“We’ve seen an increase in states setting up and opening reference labs – in part because they can provide important checks and balances on the third-party lab-testing system and because they allow states to test products directly to gain a better understanding of potential issues and to support inspection and investigation,” Schauer told MJBizDaily via email.

States with large populations, regulated marijuana markets and no plans to open a reference lab include:

Arizona
Pennsylvania
Massachusetts
New Jersey
Ohio
‘Secret shopper’ oversights
According to some critics, having a reference lab or a state contract with a third-party lab does not guarantee lab oversight.

In Massachusetts, the state Cannabis Control Commission had contracted with AtoZ Laboratories, a private lab, to test products selected off of store shelves through a “secret shopper” program.

But, according to a Friday report by The Boston Globe, the lab says state regulators have yet to send in any products for testing.

Earlier this year, the Massachusetts Cannabis Control Commission (CCC) fined multistate operator Holistic Industries after the company allegedly “knowingly” sold cannabis contaminated during a mold outbreak.

Notably, the situation came to light only after a whistleblower alerted authorities.

According to the CCC, the company sought out a lab that would perform tests that would overlook the mold.

Without reliable labs doing independent verification, critics say, the potency and safety profiles printed on legal cannabis products simply cannot be trusted.

“We definitely have no such lab here,” said Jeff Rawson, a Massachusetts-based scientist and frequent critic of regulators’ lack of testing oversight.

“The CCC is one of the worst for ignoring real problems in testing, avoiding our demands for more shelf tests and not recalling failed products.”

In some states, reference labs don’t appear to be pulling products from the shelves of marijuana stores to test product labels’ veracity, which raises questions as to what they are doing.

In New York, the Office of Cannabis Management (OCM) has a memorandum of understanding with a state Department of Public Health lab at the Wadsworth Center in Albany.

However, “To-date, the testing conducted by Wadsworth has not been targeted at validating the reliability of permitted laboratory results,” OCM spokesperson Taylor Randi Lee told MJBizDaily via email.

“OCM has a regulatory framework in place to promote the integrity of the laboratory testing that is conducted such as demonstration of laboratory capability for receiving testing approval, proficiency testing, ISO accreditation requirements, and on-site inspections,” she added.

Lee did not respond to further questions.

Reference lab costs
In New Jersey, medical marijuana was tested by the state-run Public Health and Environmental Laboratory (PHEL), which ceased testing cannabis after the state began licensing private labs.

Ahrens said she is among the lab operators who “pressed the New Jersey Cannabis Regulatory Commission many, many times to use PHEL as a reference lab to better govern the testing market.

“But the CRC has not made moves to enable (PHEL), and the excuse we’ve been given is that the CRC does not have the funds available to pay PHEL for such services.”
👍️0
doomed doomed 1 week ago
Tilray would stick out like a sore thumb at the event
Simon would not dare to show up
Nssr5 was at the bar the whole show… pissed drunk and sporting a [color=red]GO TILRAY - make cannabis great again ]
👍️0
doomed doomed 1 week ago
No shareholders in sight… they do not partake…
👍️0
doomed doomed 1 week ago
It was a Gas…
No large mold producers, heads and bcbud regulars were all there supporting the caper.
👍️0
nssrr5 nssrr5 2 weeks ago
We finally agree on something....
👍️0
nssrr5 nssrr5 2 weeks ago
Someone needs to check into rehab or simply get a life - you have however by my calculations made $1.55 with a nickel per post and can now afford to go buy yourself a beer LOL. FYI not reading or wasting my time opening a one of your doom & gloom bs posts.

You must be getting nervous with your panic morning of postings. This is a game you can not win.

Enjoy your beer!
👍️0
doomed doomed 2 weeks ago
I refuse to get a life.

👍️0
KILLAZILLA KILLAZILLA 2 weeks ago
you ARE VERY DERANGED AND OBSESSED WITH TLRY. GET A LIFE!!!
👍️0
doomed doomed 2 weeks ago
Simon buying all alcool compagnies is such a smart move.
On PAR with Bruce Linton grow mold at SCALE caper
👍️0

Your Recent History

Delayed Upgrade Clock